Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug loaded nanoparticles

The targeted delivery of anticancer agents is a promising field in anticancer therapy. Mesenchymal stem cells (MSCs) have inherent tumor-tropic and migratory properties, which allow them to serve as vehicles for targeted drug delivery systems for isolated tumors and metastatic diseases. MSCs have been successfully studied and discussed as a vehicle for cancer gene therapy. However, MSCs have not yet been discussed adequately as a potential vehicle for traditional anticancer drugs. In this review, we will examine the potential of MSCs as a targeted-delivery vehicle for anticancer drug-loaded nanoparticles (NPs), summarize various challenges, and discuss possible solutions for these challenges.From the Clinical EditorIn this review, the feasibility of mesenchymal stem cell-based targeted delivery of anticancer agents is discussed.

Graphical AbstractFigure optionsDownload high-quality image (110 K)Download as PowerPoint slide